Marjan Sepassi

Marjan Sepassi

Company: Clene Nanomedicine

Job title: Vice President - Medical Affairs


Reinventing the Surrogate Landscape: Innovating Regulatory Acceptable Endpoints Most Meaningful to People Living with ALS 2:05 pm

The recent accelerated approval brings new waves of promise for transformative ALS drugs to be approved based on surrogate markers that correlate with ALSFRS-R. With increasing demand to define more acceptable endpoints for ALS, collaborate with industry sponsors and regulatory experts to: Evaluate the potential of novel surrogate biomarkers that extend beyond ALSFRS-R to monitor…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.